151 related articles for article (PubMed ID: 10231397)
41. A comparison of the pattern of cathepsin-D expression in fibroadenoma, fibrocystic disease, preinvasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 1999 Aug; 31(3):247-51. PubMed ID: 10503271
[TBL] [Abstract][Full Text] [Related]
42. The signaling adapter protein PINCH is up-regulated in the stroma of common cancers, notably at invasive edges.
Wang-Rodriguez J; Dreilinger AD; Alsharabi GM; Rearden A
Cancer; 2002 Sep; 95(6):1387-95. PubMed ID: 12216108
[TBL] [Abstract][Full Text] [Related]
43. Expression of hyaluronan in benign and malignant breast lesions.
Auvinen PK; Parkkinen JJ; Johansson RT; Agren UM; Tammi RH; Eskelinen MJ; Kosma VM
Int J Cancer; 1997 Oct; 74(5):477-81. PubMed ID: 9355968
[TBL] [Abstract][Full Text] [Related]
44. Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer.
Bae YK; Kim A; Kim MK; Choi JE; Kang SH; Lee SJ
Hum Pathol; 2013 Oct; 44(10):2028-37. PubMed ID: 23684510
[TBL] [Abstract][Full Text] [Related]
45. Expression of proteoglycan versican in in situ breast lesions: relations between stromal changes, histotype, and invasion.
Canavese G; Candelaresi G; Castellano I; Mano MP
Pathol Res Pract; 2011 Feb; 207(2):97-103. PubMed ID: 21185131
[TBL] [Abstract][Full Text] [Related]
46. Double immunolabeling with cytokeratin and smooth-muscle actin in confirming early invasive carcinoma of breast.
Prasad ML; Hyjek E; Giri DD; Ying L; O'Leary JJ; Hoda SA
Am J Surg Pathol; 1999 Feb; 23(2):176-81. PubMed ID: 9989844
[TBL] [Abstract][Full Text] [Related]
47. Behavior of the basement membrane during carcinoma cell invasion in chemically induced carcinomas of the skin.
Köpf-Maier P; Flug M
Acta Anat (Basel); 1996; 155(1):1-13. PubMed ID: 8811110
[TBL] [Abstract][Full Text] [Related]
48. Invasion in breast lesions: the role of the epithelial-stroma barrier.
Rakha EA; Miligy IM; Gorringe KL; Toss MS; Green AR; Fox SB; Schmitt FC; Tan PH; Tse GM; Badve S; Decker T; Vincent-Salomon A; Dabbs DJ; Foschini MP; Moreno F; Wentao Y; Geyer FC; Reis-Filho JS; Pinder SE; Lakhani SR; Ellis IO
Histopathology; 2018 Jun; 72(7):1075-1083. PubMed ID: 29197112
[TBL] [Abstract][Full Text] [Related]
49. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical detection of laminin in 98 human breast carcinomas: a light and electron microscopic study.
Charpin C; Lissitzky JC; Jacquemier J; Lavaut MN; Kopp F; Pourreau-Schneider N; Martin PM; Toga M
Hum Pathol; 1986 Apr; 17(4):355-65. PubMed ID: 3514427
[TBL] [Abstract][Full Text] [Related]
51. Comparative analysis of the distribution of laminin chains in the basement membranes in some malignant epithelial tumors: the alpha1 chain of laminin shows a selected expression pattern in human carcinomas.
Määttä M; Virtanen I; Burgeson R; Autio-Harmainen H
J Histochem Cytochem; 2001 Jun; 49(6):711-26. PubMed ID: 11373318
[TBL] [Abstract][Full Text] [Related]
52. LKB1 protein expression in human breast cancer.
Fenton H; Carlile B; Montgomery EA; Carraway H; Herman J; Sahin F; Su GH; Argani P
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):146-53. PubMed ID: 16785781
[TBL] [Abstract][Full Text] [Related]
53. Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast.
Yoshida T; Matsumoto E; Hanamura N; Kalembeyi I; Katsuta K; Ishihara A; Sakakura T
J Pathol; 1997 Aug; 182(4):421-8. PubMed ID: 9306963
[TBL] [Abstract][Full Text] [Related]
54. Co-ordinate expression of the alpha-6 integrin laminin receptor sub-unit and laminin in breast cancer.
D'Ardenne AJ; Richman PI; Horton MA; Mcaulay AE; Jordan S
J Pathol; 1991 Nov; 165(3):213-20. PubMed ID: 1662264
[TBL] [Abstract][Full Text] [Related]
55. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G
J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259
[TBL] [Abstract][Full Text] [Related]
56. The H19 gene is expressed within both epithelial and stromal components of human invasive adenocarcinomas.
Dugimont T; Curgy JJ; Wernert N; Delobelle A; Raes MB; Joubel A; Stehelin D; Coll J
Biol Cell; 1995; 85(2-3):117-24. PubMed ID: 8785513
[TBL] [Abstract][Full Text] [Related]
57. Immunohistological localisation of human FAT1 (hFAT) protein in 326 breast cancers. Does this adhesion molecule have a role in pathogenesis?
Kwaepila N; Burns G; Leong AS
Pathology; 2006 Apr; 38(2):125-31. PubMed ID: 16581652
[TBL] [Abstract][Full Text] [Related]
58. Differentiation between cancerous and normal hyperplastic lobules in breast lesions.
Slater M; Danieletto S; Pooley M; Cheng Teh L; Gidley-Baird A; Barden JA
Breast Cancer Res Treat; 2004 Jan; 83(1):1-10. PubMed ID: 14997049
[TBL] [Abstract][Full Text] [Related]
59. Vimentin expression in benign and malignant breast epithelium.
Heatley M; Whiteside C; Maxwell P; Toner P
J Clin Pathol; 1993 May; 46(5):441-5. PubMed ID: 7686566
[TBL] [Abstract][Full Text] [Related]
60. Loss of basement membrane components by invasive tumors but not by their benign counterparts.
Barsky SH; Siegal GP; Jannotta F; Liotta LA
Lab Invest; 1983 Aug; 49(2):140-7. PubMed ID: 6348406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
